Movement Alert｜Insilico Medicine Rises 6.71% in Regular Trading, World AI Conference Spotlight Combines with Sector Recovery

Market Focus07-20 10:10

On July 20, Insilico Medicine rose 6.71% in regular trading, trading at HK$45.9/share, with turnover of HK$203 million.

On the news front, the World Artificial Intelligence Conference is currently underway in Shanghai, where Insilico Medicine's founder and CEO was interviewed and expressed optimistic views on China's AI development prospects. Meanwhile, the Life Sciences Tools & Services sector saw a broad recovery, with Pharmaron up 6.03%, WuXi XDC up 5.91%, WuXi Biologics up 4.87%, Joinn up 4.21%, and WuXi AppTec up 3.73%.

The rally comes amid a series of recent positive developments for the company, including a strategic alliance with Bora Pharmaceuticals potentially valued over $2.5 billion, a collaboration with Takeda Pharmaceutical worth up to $600 million, and a positive profit alert projecting first-half net profit of $33.5-39.5 million on revenue of approximately $103-107 million, marking a swing from loss to profit year-over-year.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165768266?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-20 10:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165768266","market":"us","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Rises 6.71% in Regular Trading, World AI Conference Spotlight Combines with Sector Recovery","media":"Market Focus","content":"<p><p>On July 20, Insilico Medicine rose 6.71% in regular trading, trading at HK$45.9/share, with turnover of HK$203 million.</p><p>On the news front, the World Artificial Intelligence Conference is currently underway in Shanghai, where Insilico Medicine's founder and CEO was interviewed and expressed optimistic views on China's AI development prospects. Meanwhile, the Life Sciences Tools & Services sector saw a broad recovery, with Pharmaron up 6.03%, WuXi XDC up 5.91%, WuXi Biologics up 4.87%, Joinn up 4.21%, and WuXi AppTec up 3.73%.</p><p>The rally comes amid a series of recent positive developments for the company, including a strategic alliance with Bora Pharmaceuticals potentially valued over $2.5 billion, a collaboration with Takeda Pharmaceutical worth up to $600 million, and a positive profit alert projecting first-half net profit of $33.5-39.5 million on revenue of approximately $103-107 million, marking a swing from loss to profit year-over-year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Rises 6.71% in Regular Trading, World AI Conference Spotlight Combines with Sector Recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Rises 6.71% in Regular Trading, World AI Conference Spotlight Combines with Sector Recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-20 10:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 20, Insilico Medicine rose 6.71% in regular trading, trading at HK$45.9/share, with turnover of HK$203 million.</p><p>On the news front, the World Artificial Intelligence Conference is currently underway in Shanghai, where Insilico Medicine's founder and CEO was interviewed and expressed optimistic views on China's AI development prospects. Meanwhile, the Life Sciences Tools & Services sector saw a broad recovery, with Pharmaron up 6.03%, WuXi XDC up 5.91%, WuXi Biologics up 4.87%, Joinn up 4.21%, and WuXi AppTec up 3.73%.</p><p>The rally comes amid a series of recent positive developments for the company, including a strategic alliance with Bora Pharmaceuticals potentially valued over $2.5 billion, a collaboration with Takeda Pharmaceutical worth up to $600 million, and a positive profit alert projecting first-half net profit of $33.5-39.5 million on revenue of approximately $103-107 million, marking a swing from loss to profit year-over-year.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1165768266","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165768266","pubTimestamp":1784513446,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 20, Insilico Medicine rose 6.71% in regular trading, trading at HK$45.9/share, with turnover of HK$203 million.On the news front, the World Artificial Intelligence Conference is currently...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"走势提醒|Insilico Medicine 常规交易上涨 6.71%，世界人工智能大会聚焦与行业复苏相结合","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On July 20, Insilico Medicine rose 6.71% in regular trading, trading at HK$45.9/share, with turnover of HK$203 million.On the news front, the World Artificial Intelligence Conference is currently underway in Shanghai, where Insilico Medicine's founder and CEO was interviewed and expressed optimistic views on China's AI development prospects. Meanwhile, the Life Sciences Tools & Services sector saw a broad recovery, with Pharmaron up 6.03%, WuXi XDC up 5.91%, WuXi Biologics up 4.87%, Joinn up 4.21%, and WuXi AppTec up 3.73%.The rally comes amid a series of recent positive developments for the company, including a strategic alliance with Bora Pharmaceuticals potentially valued over $2.5 billion, a collaboration with Takeda Pharmaceutical worth up to $600 million, and a positive profit alert projecting first-half net profit of $33.5-39.5 million on revenue of approximately $103-107 million, marking a swing from loss to profit year-over-year.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165768266","isCrawlerRequest":true}